I. Cucos, MD, Rheumatology Department, Pitié-Salpêtrière Hospital, AP-HP, Paris;
S. Dadoun, MD, C. Hudry, MD, Private Practice, Paris.
J Rheumatol. 2021 Jul;48(7):1002-1006. doi: 10.3899/jrheum.191397. Epub 2020 Sep 15.
Axial spondyloarthritis (axSpA) may have an effect on work. The Ankylosing Spondylitis Work Instability Scale (AS-WIS) assesses difficulties at work. The objective of this study was to evaluate the predictive value of the AS-WIS on work impact.
This is a prospective cohort study with 2 timepoints (at baseline and after 1.5 yrs) that included patients with axSpA who had paid employment. Patients completed the AS-WIS at baseline and work instability was scored as moderate/high if ≥ 11 (0-20 scale). At follow-up, adverse work outcomes (AWO) were grouped as moderate (short-term sick leave) or severe AWO (long-term sick leave, disability, unemployment). Univariable and multivariable logistic regression analyses were performed to explain AWO.
Of 101 patients, mean age 45 (SD 9) years, 52% male, disease duration was 14 (SD 8) years. The Bath AS Disease Activity Index and the Bath AS Functional Index were 34 (SD 21) and 23 (SD 23), respectively, and 69 (68%) received a tumor necrosis factor inhibitor. At baseline, 46 (46%) patients had moderate/high AS-WIS. At 1.5 years of follow-up, 37 patients (36%) had AWO: 25 patients (25%) a short-term sick leave, and 12 patients (12%, 7/100 patient-years) a severe AWO. Independent baseline factors associated with AWO were a moderate/high AS-WIS score (OR 2.71, 95% CI 1.04-7.22) and shorter disease duration (OR 0.94, 95% CI 0.89-0.99).
In patients with axSpA, a moderate/high AS-WIS score was predictive of AWO in this population with well-controlled axSpA. This short questionnaire can be helpful to screen for future difficulties at work.
强直性脊柱炎(axSpA)可能会对工作产生影响。强直性脊柱炎工作不稳定量表(AS-WIS)评估工作中的困难。本研究的目的是评估 AS-WIS 对工作影响的预测价值。
这是一项前瞻性队列研究,有 2 个时间点(基线和 1.5 年后),包括有薪就业的 axSpA 患者。患者在基线时完成 AS-WIS,评分≥11 分(0-20 分)为中/高度工作不稳定。在随访时,将不良工作结果(AWO)分为中度(短期病假)或重度 AWO(长期病假、残疾、失业)。进行单变量和多变量逻辑回归分析,以解释 AWO。
101 例患者中,平均年龄 45(SD 9)岁,52%为男性,疾病病程为 14(SD 8)年。Bath AS 疾病活动指数和 Bath AS 功能指数分别为 34(SD 21)和 23(SD 23),69%(69/101)接受肿瘤坏死因子抑制剂治疗。基线时,46(46%)例患者的 AS-WIS 为中/高度。1.5 年随访时,37 例患者(36%)发生 AWO:25 例(25%)短期病假,12 例(12%,100 例患者-年中有 7 例)严重 AWO。与 AWO 相关的独立基线因素包括中/高度 AS-WIS 评分(OR 2.71,95%CI 1.04-7.22)和较短的病程(OR 0.94,95%CI 0.89-0.99)。
在 axSpA 患者中,中/高度 AS-WIS 评分可预测该人群 axSpA 控制良好时的 AWO。这个简短的问卷可以帮助筛查未来的工作困难。